WSJ.com: US Business
GSK Heart Drug Disappoints
[unable to retrieve full-text content]One of GlaxoSmithKline's major drug investments has failed to lower the risk of heart attack or stroke among chronic-heart-disease patients, the company said after it concluded the first of two late-stage trials of the drug.
0 comments:
Post a Comment